Accessibility Menu
Intelicare logo

Intelicare

(ASX) ICR

Current PriceA$0.02
Market CapA$16.45M
Since IPO (2020)-92%
5 Year-90%
1 Year+283%
1 Month-8%

Intelicare Financials at a Glance

Market Cap

A$16.45M

Revenue (TTM)

A$1.60M

Net Income (TTM)

-A$5.21M

EPS (TTM)

-A$0.01

P/E Ratio

-4.26

Dividend

A$0.00

Beta (Volatility)

-0.01 (Low)

Price

A$0.02

Volume

48,774

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.01 - A$0.04

Estimated Earnings Date

Sep 2, 2026

ICR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intelicare

Industry

Health Care Technology

CEO

Daniel Pilbrow

Headquarters

Leederville, WA 6007, AU

ICR Financials

Key Financial Metrics (TTM)

Gross Margin

-6%

Operating Margin

-11%

Net Income Margin

-8%

Return on Equity

-1487%

Return on Capital

18%

Return on Assets

-1%

Earnings Yield

-23.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$16.45M

Shares Outstanding

715.31M

Volume

48.77K

Avg. Volume

493.03K

Financials (TTM)

Gross Profit

-A$1.09M

Operating Income

-A$2.69M

EBITDA

-A$2.16M

Operating Cash Flow

-A$1.67M

Capital Expenditure

-A$7.09K

Free Cash Flow

-A$1.67M

Cash & ST Invst.

A$410.53K

Total Debt

A$716.62K

Intelicare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$489.71K

+299.2%

Gross Profit

-A$644.02K

+25.5%

Gross Margin

-1.32%

N/A

Market Cap

A$16.45M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-A$1.37M

-106.6%

EBITDA

-A$1.23M

+17.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$1.05M

-25.6%

Total Debt

A$1.09M

+256.3%

Accounts Receivable

A$188.58K

+136.9%

Inventory

A$209.54K

-24.6%

Long Term Debt

A$17.83K

N/A

Short Term Debt

A$1.07M

+250.5%

Return on Assets

-1.49%

N/A

Return on Invested Capital

18.46%

N/A

Free Cash Flow

-A$1.54M

-226.9%

Operating Cash Flow

-A$1.54M

-226.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IXC.AXInvex Therapeutics Ltd
A$0.12+31.87%
VBS.AXVectus Biosystems Limited
A$0.14+0.00%
BGT.AXBio-Gene Technology Limited
A$0.02+10.00%
HIQ.AXHITIQ Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$124.57+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
SMCISuper Micro Computer
$30.46-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About ICR

What is the current price of Intelicare?

Intelicare is trading at A$0.02 per share.

What is the 52-week range for Intelicare?

Over the past 52 weeks, Intelicare has traded between A$0.01 and A$0.04.

How much debt does Intelicare have?

As of the most recent reporting period, Intelicare reported total debt of A$716.62K.

How much cash does Intelicare have on hand?

Intelicare reported A$410.53K in cash and cash equivalents in its most recent financial results.

What is Intelicare’s dividend yield?

Intelicare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.